Decline depth
-20.2%
From rolling 252-day high of $11.31, 346d ago.
Past the 20% Watch threshold.
Watch
BCRX
BioCryst Pharmaceuticals, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic · mid-cap ($2.3B)
-20.2%
from rolling 252-day high of $11.31 set 2025-06-04 · 346d ago
Current
$9.02
Decline depth
-20.2%
Decline σ
2.4σ
TFC
1/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Structural break signals
BCRX qualifies for the Watch on decline depth.
Time-frame continuity
1/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
2.4σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (3.54% per day).
The structural read
What price action says about BCRX.
BCRX qualifies for the Watch on decline depth — down -20.2% from its rolling 252-day high.
Upstream TFC read: weak alignment, current phase weekly. Last bar types — daily 2D (red), weekly 2U (green), monthly 2D (red).
Earnings on file: 2026-05-06. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $6.00
56.9% of range
52W high $11.31
Sector context · Healthcare
215 other Healthcare tickers are on Broken Stocks.
107
Red List
57
Amber
51
Watch
-34.8%
Median decline
Worst in sector: OPRX (-76.6%). Least-bad: KYMR (-20.2%). See all Healthcare listings →
Related — same sector
Closest decliners to BCRX
Watch
KYMR
Kymera Therapeutics, Inc.
Watch Recovering
THC
Tenet Healthcare Corporation
Watch
RVTY
Revvity, Inc.
Watch Recovering
WAT
Waters Corporation
Amber List
INFU
InfuSystems Holdings, Inc.
Watch
MGTX
MeiraGTx Holdings plc
Questions about BCRX
What people ask.
Why is BCRX on Broken Stocks?
BCRX qualifies for the Watch on decline depth. It is down -20.2% from its rolling 252-day high of $11.31, set on 2025-06-04 — 346d ago.
Is BCRX a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. BCRX is down -20.2% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is BCRX a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is BCRX trading inside its 52-week range?
At $9.02, BCRX sits 56.9% of the way from its 52-week low ($6.00) to its 52-week high ($11.31). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has BCRX been declining?
The current 20.2% decline accrued over 346d, which annualizes to roughly -21.3% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does BCRX compare to its sector?
There are 215 other Healthcare tickers on Broken Stocks: 107 Red, 57 Amber, 51 Watch, with 24 showing recovering structural signals. Median sector decline is -34.8% — BCRX's decline is shallower than the sector median.
Does BCRX's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-06) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.